JUN 24, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Imiquimod (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for imiquimod labeling update; regulatory action record containing no clinical trial data or efficacy comparisons.
Reported
Approval date2026-06-24
Active ingredient and strengthImiquimod 5%
FormulationCream, topical